Delve into dermatology diseases with new approaches from conventional to complementary care.
Explore a broad spectrum of dermatological conditions and topics to enhance your practice.
Expert led instruction for every level of patient care.
Log in to see enrolled program content.
Gain practical insights and meet new colleagues.
Hover over a conference to view recordings.
The largest integrative dermatology community.


Neal Bhatia, MD is a board-certified dermatologist in San Diego, California. He serves as Director of Clinical Dermatology at Therapeutics Clinical Research and as chief medical editor for Practical Dermatology. He is widely published and has a background in immunology as well as interests in mechanisms of therapy, skin cancer, and medical dermatology.
Recording and Handouts from 2019 Integrative Dermatology Symposium.

In this webinar, we review the basic virology of COVID-19 (SARS-CoV-2), including the cellular entry pathways through the ACE2 receptor. We then discuss the use of spironolactone and its possible association to ACE2 expression. We conclude with case studies and explore the use of isotretinoin from a practical perspective in the setting of physically distant management and COVID-19 infection.

In this webinar, we review the use of biologics during COVID-19 in diseases such as psoriasis, atopic dermatitis, and hidradenitis suppurativa. Using a case-based approach, the discussions cover a summary of immunosuppressive actions for the different biologics, risk for use in infection, considerations when choosing between biologics, and accounting for a patient’s comorbidities.

In this webinar, the panel reviews challenging cases in moderate to severe acne and rosacea, discussing the use of antibiotics and systemic medications, examining new and emerging topical therapies, and reviewing how to incorporate nutrition and supplements into a treatment plan.

Acne and rosacea are widely prevalent in the general population and two of the most common skin conditions seen in clinic. This program will review the latest research and emerging therapies in acne and rosacea, including topics that will cover pharmaceuticals, cosmeceuticals, devices, nutrition, probiotics, and supplements. Strategies to reduce the use of oral antibiotics will also be discussed.

This course reviews the unique challenges that arise with treating acne in those with darker skin tones. Topical therapies and strategies are reviewed along with a discussion of approaches to treatment during isotretinoin.

Actinic keratoses have many treatment options, and this activity will discuss emerging data for field treatment of actinic keratoses. Treatment options will be summarized and reviewed in the context of clinical care.

With the rise in vaccinations for COVID-19 and the need for boosters in the future, the safety for those on immunomodulating and immunosuppressive medications needs to be considered. This webinar panel discusses immunosuppressants and biologic adjustments based on vaccinations and COVID-19 with case-based examples.

Oral antibiotics are frequently prescribed in the treatment of rosacea. This webinar panel discusses emerging data in relation to novel and emerging topical and oral treatments for rosacea from an evidence-based perspective.

There has been an explosion of biologic and small molecules for the treatment of several chronic skin conditions, such as psoriasis, atopic dermatitis, and hidradenitis suppurativa. These medications are reviewed in the context of clinical cases and how they can be incorporated into clinical use.

Acne is one of the most prevalent skin conditions that affects both adolescents and adults. This webinar will review the evidence for novel medications and emerging probiotics. As there are many variations in acne, personalization is an important aspect of acne treatment. We will discuss personalization in the context of common skin types, the subtypes of acne, and how this affects the choice of treatment regimens.









